Journals / Turkish Journal of Gastroenterology / 2005 / Cilt: 16 - Sayı: 2

Kronik intestinal psödoobstrüksiyon: 4 çocuk olgunun sunumu

Chronic intestinal pseudoobstruction: Report of four pediatric patients

Pages
93–97
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Octreotide was effective in this case.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Chronic intestinal pseudoobstruction is a rare disorder of intestinal motility, characterized by recurrence of continuous symptoms and signs of intestinal obstruction in the absence of true mechanical obstruction.
📊
Key Findings & Data:Congenital or systemic disorders are the causes of chronic intestinal pseudoobstruction.
💡
Conclusion & Impact:Octreotide was effective in this case.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Bağırsak yalancı-tıkanıklığı · Kronik hastalık · Oktreotid

Abstract

Chronic intestinal pseudoobstruction is a rare disorder of intestinal motility, characterized by recurrence of continuous symptoms and signs of intestinal obstruction in the absence of true mechanical obstruction. Congenital or systemic disorders are the causes of chronic intestinal pseudoobstruction. The term idiopathic is applied when there is no congenital or secondary cause. Early diagnosis of intestinal pseudoobstruction is important to avoid repeated laparotomies. Treatment of chronic intestinal pseudoobstruction is usually supportive. Besides the supportive therapy, prokinetic agents such as erythromycin and octreotide are used in the therapy. In this article, four pediatric patients diagnosed as chronic intestinal pseudoobstruction are discussed with their clinical findings and laboratory abnormalities. The etiology of chronic intestinal pseudoobstruction was visceral myopathy in one patient. Two had idiopathic chronic intestinal pseudoobstruction and the other patient developed chronic intestinal pseudoobstruction after cardiac surgery. Erythromycin was administered to all four patients, one of whom did not respond to this therapy. Octreotide was effective in this case.

Özet

Kronik intestinal psödoobstrüksiyon nadir görülen intestinal motilite hastalığıdır. Mekanik obstrüksiyon bulgusu olmaksızın intestinal obstrüksiyonun tekrarlayan veya devamlı bulguları ile karakterizedir. Konjenital veya sistemik hastalıklar etyolojide rol oynar. Konjenital veya sekonder bir sebep tespit edilemediğ inde hastalık idiyopatik olarak isimlendirilir. İntestinal psödoobstrüksiyon tanısı erken konulduğunda gereksiz cerrahi girişimlerden kaçınılmış olur. Psödoobstrüksiyonun tedavisinde destekleyici tedaviler yanında oktreotid gibi prokinetik ilaçlar da kullanılmaktadır. Bu makalede kronik intestinal psödoobstrüksiyonlu dört çocuk olgunun klinik ve laboratuvar bulguları tartışıldı. Hastalardan birinde etyolojiden geçirilmiş kardiyak cerrahi, diğerinde viseral myopati sorumlu idi. Diğer iki hastada sebep bulunamadı ve idiyopatik olarak kabul edildi. Hastaların hepsine eritromisin tedavisi verildi. Bir olgu eritromisin tedavisine yanıt vermeyince oktreotid kullanıldı. Bu hastada oktreotid tedavisine çok iyi yanıt alındı.

🔖

Cite This Article

DALGIÇ, B., SARI, S., DOĞAN, İ., ÜNAL, S. (2005). Kronik intestinal psödoobstrüksiyon: 4 çocuk olgunun sunumu. Turkish Journal of Gastroenterology, Cilt: 16 - Sayı: 2, 93–97. https://ajindex.com/articles/410886

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Rudolph CD, Hyman PE, Altschuler SM, et al. Diagnosis and treatment of chronic intestinal pseudo-obstruction in children: report of consensus workshop. J Pediatr Gastroenterol Nutr 1997; 24: 102-12
  2. Smith DS, Williams CS, Ferris CD. Diagnosis and treatment of chronic gastroparesis and chronic intestinal pseudo- obstruction. Gastroenterol Clin N Am 2003; 32: 619-58
  3. Di Lorenzo C. Pseudo-obstruction: current approaches. Gastroenterology 1999; 116: 980-7
  4. Thiel ER, Bircks W. Acute pseudo-obstruction of the colon (Ogilvie's syndrome) following open heart surgery. Thorac Cardiovasc Surg 1990 Dec; 38(6): 371-3
  5. Rohrman CA, Ricci MT, Krishnamurthy S, et al. Radiologic and histologic differentiation of neuromuscular disorders of the gastrointestinal tract. Visceral neuropathies and progressive systemic sclerosis. AJR 1984; 143: 933-41
  6. Faure C, Goulet O, Ategbo S, et al. Chronic intestinal pseudo- obstruction syndrome: clinical analysis, outcome, and prognosis in 105 children. Dig Dis Sci 1999; 44: 953-9
  7. Almeida PS, Penna FJ. Chronic intestinal pseudo-obstruction in childhood - report of seven cases. J Pediatr 2000; 76:453-7
  8. Goulet O, Talbotec C, Ricour JC. Nutritional management of pediatric patients with chronic intestinal pseudo-obstruction syndrome. J Pediatr Gastroenterol Nutr 2001; 32: 44-7
  9. Laustsen J, Harling H, Fallingborg J. Treatment of chronic idiopathic intestinal pseudo-obstruction. Dig Dis Sci 1987; 32: 222-3
  10. Berger SA, Keshavarzian A, DeMeo MT, et al. Erythromycin in chronic intestinal pseudo-obstruction. J Clin Gastroenterol 1990; 12: 363
  11. Camillieri M, Balm RK, Zinsmeister AR. Determinants of response to a prokinetic agent in neuropathic chronic intestinal motility disorder. Gastroenterology 1994; 106: 916-23
  12. Vargas JH, Sachs P, Ament ME. Chronic intestinal pseudoobstruction syndrome in pediatrics: results of a national survey by members of the North American Society of Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr 1988; 7: 323-32
  13. Cucchiara S, Minella R, Scoppa A. Antroduodenal motor effects of intravenous erythromycin in children with abnormalities of gastrointestinal motility. J Pediatr Gastroenterol Nutr 1997; 24: 411-8
  14. Soudah HC, Hasler W, Owyang C. Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. N Engl J Med 1991; 325: 1461-7
  15. Marie I, Kerleau JM, Ducrotte P, et al. Intravenous immunoglobulins and octreotide as treatment of